Knee Osteoarthritis Steroid Injection Study for People with Type 2 Diabetes
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study compares two different steroid knee injections—Zilretta and Kenalog—to see which works better for people with both knee osteoarthritis and type 2 diabetes. It uses a continuous glucose monitor to track blood sugar changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have type 2 diabetes for at least 1 year and are taking diabetes medication (pills or non-insulin shots) that has been stable for at least 1 month.
- You have moderate to severe knee pain from osteoarthritis for at least 6 months (a 4-9 on a 0-10 scale).
- You have not had a steroid shot in your knee, muscle, or vein in the last 3 months.
- You are willing to wear a continuous glucose monitor (CGM) on your arm for up to 24 hours a day during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if steroid injections for knee arthritis work in people with obesity. It may help you manage pain and avoid surgery.
This study compares two ways of injecting a steroid medication into arthritic knees: using landmark guidance (traditional method) with a higher dose versus ultrasound guidance (imaging) with a lower dose. The goal is to see which approach works better to reduce knee pain and improve function.
This trial compares different doses of injected cortisone (triamcinolone) directly into the knee to see which dose helps knee osteoarthritis pain most. You may be enrolled in a group receiving a 5 mg, 10 mg, or 40 mg dose if you meet the study’s knee and health requirements.
This study tests a new injection for knee osteoarthritis that aims to improve pain and function. It may help if you have moderate to severe knee pain that hasn't been relieved by first-line treatments.
This study tests whether a single steroid injection in the healthy knee (the one not being replaced) can reduce pain and improve recovery after total knee replacement. It may help people who have arthritis in both knees but are only having one replaced now.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
Hear when a new Osteoarthritis, Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.